Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the 'Contacts and Locations' section in the study record.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew features have been added to the website, while several detailed data fields and options for downloading study information have been removed.SummaryDifference3%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
- Check37 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.